Fund overlap
Nippon India Pharma Fund vs Mirae Asset Healthcare Fund
Fund A
Nippon India Pharma Fund
Nippon India Pharma Fund - Direct Plan - IDCW Option
Open Ended Schemes(Equity Schemes - Sectoral Fund) · Nippon India Mutual Fund
Fund B
Mirae Asset Healthcare Fund
Mirae Asset Healthcare Fund - Direct Plan - Growth
Open Ended Schemes(Equity Schemes - Thematic Fund) · Mirae Asset Mutual Fund
Overlap
37.1%
- Shared holdings
- 19
- Holdings in A
- 38
- Holdings in B
- 31
Overlap measures how closely the two portfolios match, holding by holding and weight by weight, using each fund's latest disclosed holdings. 100% would mean the same holdings at the same weights.
Shared holdings
The 10 largest of 19 shared holdings, ordered by the smaller of the two weights.
| Holding | Nippon India Pharma Fund | Mirae Asset Healthcare Fund |
|---|---|---|
| Sun Pharmaceutical Industries Limited | 11.71% | 10.15% |
| Divi's Laboratories Limited | 7.10% | 9.79% |
| Apollo Hospitals Enterprise Limited | 4.89% | 5.62% |
| Dr. Reddy's Laboratories Limited | 5.45% | 4.84% |
| Sai Life Sciences Limited | 3.92% | 3.23% |
| IPCA Laboratories Limited | 2.87% | 3.39% |
| Cipla Limited | 6.01% | 2.63% |
| Gland Pharma Limited | 2.53% | 2.69% |
| Max Healthcare Institute Limited | 2.70% | 2.35% |
| Lupin Limited | 6.17% | 2.27% |
Data as of 30 Sept 2026
Method: weighted Jaccard
Weighted Jaccard adds up the smaller weight of every holding across both funds and divides by the sum of the larger weights.